CaroSpir

Last Updated: 04/28/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8402 publications

Diagnosis and Management of Resistant Hypertension: A Review.

Diagnosis and Management of Resistant Hypertension: A Review.

Journal: JAMA
Published: March 23, 2026

Can we differentiate between finerenone, eplerenone and spironolactone in HFmrEF/HFpEF through a Bayesian lens?

Can we differentiate between finerenone, eplerenone and spironolactone in HFmrEF/HFpEF through a Bayesian lens?

Journal: European journal of heart failure
Published: March 22, 2026

Spironolactone rules.

Spironolactone rules.

Journal: Journal of the American Academy of Dermatology
Published: March 21, 2026

Uncontrolled hypertension in siblings: an unsuspected diagnosis.

Uncontrolled hypertension in siblings: an unsuspected diagnosis.

Journal: AJOG global reports
Published: March 19, 2026

Left Atrial Volume Index and Left Ventricular Mass Index Determine the Benefits of Spironolactone in Patients With Heart Failure With Preserved Ejection Fraction.

Left Atrial Volume Index and Left Ventricular Mass Index Determine the Benefits of Spironolactone in Patients With Heart Failure With Preserved Ejection Fraction.

Journal: Journal of the American Heart Association
Published: March 18, 2026

Real-world effectiveness and safety of torsemide and spironolactone fixed dose combination in Indian heart failure patients (RESTORE-HF study): a prospective, multicenter, observational study.

Real-world effectiveness and safety of torsemide and spironolactone fixed dose combination in Indian heart failure patients (RESTORE-HF study): a prospective, multicenter, observational study.

Journal: Therapeutic advances in cardiovascular disease
Published: March 17, 2026

Real-World Benefit of Spironolactone and Eplerenone in HFpEF: Evidence From a Large-Scale Observational Study.

Real-World Benefit of Spironolactone and Eplerenone in HFpEF: Evidence From a Large-Scale Observational Study.

Journal: American journal of therapeutics
Published: March 17, 2026

Differential cardiometabolic outcomes of leuprolide versus spironolactone in women with polycystic ovary syndrome.

Differential cardiometabolic outcomes of leuprolide versus spironolactone in women with polycystic ovary syndrome.

Journal: Proceedings (Baylor University. Medical Center)
Published: March 16, 2026

The Pharmacological Properties and Safety Profile of Mineralocorticoid Receptor Antagonists in Heart Failure with Reduced Ejection Fraction.

The Pharmacological Properties and Safety Profile of Mineralocorticoid Receptor Antagonists in Heart Failure with Reduced Ejection Fraction.

Journal: The Journal of the Association of Physicians of India
Published: March 12, 2026

Risk of Delaying or Omitting Mineralocorticoid Receptor Antagonists in Heart Failure.

Risk of Delaying or Omitting Mineralocorticoid Receptor Antagonists in Heart Failure.

Journal: The Journal of the Association of Physicians of India
Published: March 12, 2026

Mineralocorticoid Receptor Antagonists: An Overview of History and Evolution.

Mineralocorticoid Receptor Antagonists: An Overview of History and Evolution.

Journal: The Journal of the Association of Physicians of India
Published: March 12, 2026

Mineralocorticoid Receptor Antagonists: The Pillar Drug in Heart Failure.

Mineralocorticoid Receptor Antagonists: The Pillar Drug in Heart Failure.

Journal: The Journal of the Association of Physicians of India
Published: March 12, 2026
Showing 1-12 of 8,402

Last Updated: 04/28/2026